Product Details for ANDA 075572
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
5MG
Marketing Status: Discontinued
10MG
Marketing Status: Discontinued
15MG
Marketing Status: Discontinued
5MG
Marketing Status: Discontinued
Active Ingredient: BUSPIRONE HYDROCHLORIDE
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075572
Product Number: 001
Approval Date: Feb 27, 2002
Applicant Holder Full Name: NESHER PHARMACEUTICALS USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075572
Product Number: 001
Approval Date: Feb 27, 2002
Applicant Holder Full Name: NESHER PHARMACEUTICALS USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
10MG
Marketing Status: Discontinued
Active Ingredient: BUSPIRONE HYDROCHLORIDE
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075572
Product Number: 002
Approval Date: Feb 27, 2002
Applicant Holder Full Name: NESHER PHARMACEUTICALS USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
BUSPIRONE HYDROCHLORIDE (BUSPIRONE HYDROCHLORIDE)
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075572
Product Number: 002
Approval Date: Feb 27, 2002
Applicant Holder Full Name: NESHER PHARMACEUTICALS USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
15MG
Marketing Status: Discontinued
Active Ingredient: BUSPIRONE HYDROCHLORIDE
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075572
Product Number: 003
Approval Date: Feb 27, 2002
Applicant Holder Full Name: NESHER PHARMACEUTICALS USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: BUSPIRONE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A075572
Product Number: 003
Approval Date: Feb 27, 2002
Applicant Holder Full Name: NESHER PHARMACEUTICALS USA LLC
Marketing Status: Discontinued
Patent and Exclusivity Information